Will Disney Collaboration Help BBWI Expand Its Brand or Merely Boost Short-Term Buzz?

Bath & Body Works, Inc. -3.93%

Bath & Body Works, Inc.

BBWI

18.57

-3.93%

  • Bath & Body Works recently launched its new Disney Villains fragrance collection worldwide, featuring products inspired by Maleficent and the Evil Queen, with early access for loyalty members and a broader release on September 3, 2025.
  • This marks the first time a Bath & Body Works collaboration with Disney has launched simultaneously in both domestic and international markets, providing fans across the globe immediate access and highlighting the expanding partnership between the two brands.
  • We’ll now explore how the global launch and deeper Disney partnership may influence Bath & Body Works’ investment narrative and future growth prospects.

Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.

Bath & Body Works Investment Narrative Recap

To own Bath & Body Works stock today, investors need to believe the brand’s product expansion, global collaborations, and loyalty program can reignite consistent growth and margin stability, despite recent declines in net sales. The global Disney Villains collection launch showcases the company’s ability to create high-visibility moments, supporting near-term catalysts like new customer acquisition and loyalty program growth, but execution risks remain, should the product fail to connect with international markets, anticipated sales gains may not be material.

Among recent developments, the August 6 expansion into more than 600 college campus stores is particularly relevant. Engaging younger consumers directly aligns with the Disney collaboration’s goals of attracting diverse, new audiences and encourages further brand loyalty, potentially supporting future growth if these efforts sustain momentum and broaden Bath & Body Works’ customer base.

Yet, in contrast, investors should be mindful of potential challenges around maintaining top-line growth if...

Bath & Body Works is projected to reach $8.0 billion in revenue and $835.3 million in earnings by 2028. This outlook assumes annual revenue growth of 2.8% and an earnings increase of $19.3 million from the current earnings of $816.0 million.

Uncover how Bath & Body Works' forecasts yield a $40.93 fair value, a 32% upside to its current price.

Exploring Other Perspectives

BBWI Community Fair Values as at Aug 2025
BBWI Community Fair Values as at Aug 2025

Simply Wall St Community members have published 7 fair value estimates for Bath & Body Works, ranging from US$32 to US$70 per share. While many see significant opportunity, ongoing execution risks around new product launches continue to shape expectations for future revenue and margin performance.

Explore 7 other fair value estimates on Bath & Body Works - why the stock might be worth just $32.00!

Build Your Own Bath & Body Works Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Bath & Body Works research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free Bath & Body Works research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bath & Body Works' overall financial health at a glance.

Interested In Other Possibilities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

  • AI is about to change healthcare. These 28 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Find companies with promising cash flow potential yet trading below their fair value.
  • Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.